Search - tctmd.com

Displaying 1 - 20 of 895

Sort: Relevancy | Date

Presentation Miami Valves 2025

Novel Device for Pulmonic Valve: Alterra

Presenter: Pedro Villablanca

January 30, 2025

Presentation Miami Valves 2025

Novel TMVR Devices: CAPSTAN Medical

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Dedicated TAVR Devices for Chronic Aortic Regurgitation

Presenter: Santiago Garcia

January 30, 2025

Presentation Cardiovascular Interventions 2024

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

Presenter: Matthew J. Price

November 11, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Presenter: Tomas Kovarnik

October 30, 2024

Presentation TCT 2024

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

Presenter: Seun Alli

October 30, 2024

Presentation TCT 2024

One-Year Follow-Up of the US Early Feasibility Study Evaluating Rotational Closure of the LAA Using the Laminar Device

Presenter: Saibal Kar

October 30, 2024

Presentation TCT 2024

TCT 550: Cardiovascular Outcomes and Comparison of Low vs Intermediate High Hospital Frailty Index on Watchman Device and Associated Readmissions: A Nationwide Readmission Database Analysis

Presenter: Krutarth Pandya

October 30, 2024

Presentation TCT 2024

TCT 549: Association of Left Atrial Appendage Anatomy With Peri-Device Leak at Mid-Term Follow Up

Presenter: Lu Chen

October 30, 2024

Presentation TCT 2024

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Presenter: Jerry Lipinski

October 30, 2024

Presentation TCT 2024

Technical Enhancements and Case Vignettes from Second Generation TMVR Devices

Presenter: Pradeep Yadav

October 30, 2024

Presentation TCT 2024

Report of an IDE Pivotal Study of a Mechanical Leaflet Splitting Device During TAVR (SHORTCUT)

Presenter: Danny Dvir

October 30, 2024

Presentation TCT 2024

CONTROVERSY: Device Selection and Sizing for TAVR in BAVD

Presenter: Didier Tchetche

October 30, 2024

Presentation TCT 2024

TCT 1097: Could We Have Any More Intervention in This Lady? Can Device Implantation Help in Recurrent Heart Failure in a Middle-Aged Lady With LBBB and VT?

Presenter: Ujjawal Kumar

October 29, 2024

Presentation TCT 2024

TCT 913: Procedural Aspects of Transcatheter Aortic Valve Replacement: Comparison Between Balloon-Expandable and Self-Expanding Devices

Presenter: Judit Andréka

October 29, 2024

Presentation TCT 2024

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

Presenter: Dilesha Kumanayaka

October 29, 2024

Presentation TCT 2024

Topic 2: T-TEER: Choosing the Right Device According to the Anatomy

Presenter: Amar Krishnaswamy

October 29, 2024

Presentation TCT 2024

TCT 1469: No Time to Spare: Post TAVR AI and Hemodynamic Instability After CoreValve Deployment Treated With Valve-in-Valve Placement of Sapien Device

Presenter: Muhammad Sabih Saleem

October 29, 2024

Advertisement

Novel Device for Pulmonic Valve: Alterra

Novel TMVR Devices: CAPSTAN Medical

Dedicated TAVR Devices for Chronic Aortic Regurgitation

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

One-Year Follow-Up of the US Early Feasibility Study Evaluating Rotational Closure of the LAA Using the Laminar Device

TCT 550: Cardiovascular Outcomes and Comparison of Low vs Intermediate High Hospital Frailty Index on Watchman Device and Associated Readmissions: A Nationwide Readmission Database Analysis

TCT 549: Association of Left Atrial Appendage Anatomy With Peri-Device Leak at Mid-Term Follow Up

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Technical Enhancements and Case Vignettes from Second Generation TMVR Devices

Report of an IDE Pivotal Study of a Mechanical Leaflet Splitting Device During TAVR (SHORTCUT)

CONTROVERSY: Device Selection and Sizing for TAVR in BAVD

TCT 1097: Could We Have Any More Intervention in This Lady? Can Device Implantation Help in Recurrent Heart Failure in a Middle-Aged Lady With LBBB and VT?

TCT 913: Procedural Aspects of Transcatheter Aortic Valve Replacement: Comparison Between Balloon-Expandable and Self-Expanding Devices

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

Topic 2: T-TEER: Choosing the Right Device According to the Anatomy

TCT 1469: No Time to Spare: Post TAVR AI and Hemodynamic Instability After CoreValve Deployment Treated With Valve-in-Valve Placement of Sapien Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content